Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0001104659-24-132167

Chief Executive Officer sold 19,106 shares at $7.43 ($141,958)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Barrow Robert · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-12-26 Sale : show line 1 in the form 10b5-1 −19,106 $7.43 $141,958 526,666 D
Open-market sales · 19,106 sh · avg $7.43 · $141,958
Loading xslF345X05/tm2432133-4_4seq1.xml…